The Cancer Genome Atlas network recently published findings again demonstrating the four distinct molecular signatures in breast cancer from diverse genetic and epigenetic alterations: luminal A, luminal B, basal-like, and HER-2 enriched subtypes (55). This evidence concerns the gene ERBB2 and breast cancer.